BeyondSpring is trading 9.18% up at $0.56, with broader biotech-sector strength a possible source of support; no company-specific announcement explaining the October 20 move surfaced. - XBI is up 2.10%, alongside sector optimism around M&A and clinical trials. - The latest company headlines found were earlier announcements, not a fresh catalyst.